Immunomodulation of human islets results in prolonged in vivo islet graft survival.
Zeng
Y
Y
Department of Surgery, University of Chicago, IL 60637.
Peterson
L
L
Levisetti
M
M
Torres
M
M
Montag
A
A
Thistlethwaite
J R
JR
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D002478:Cells, Cultured; D015925:Cryopreservation; D003921:Diabetes Mellitus, Experimental / Q000628:therapy*; D006085:Graft Survival; D006681:HLA-D Antigens / Q000276:immunology; D006801:Humans; D007515:Islets of Langerhans / Q000166:cytology; D016381:Islets of Langerhans Transplantation / Q000276:immunology / Q000502:physiology*; D017710:Lymphocyte Transfusion; D051379:Mice; D016513:Mice, SCID; D014183:Transplantation, Heterologous / Q000276:immunology / Q000502:physiology*
D000911:Antibodies, Monoclonal; D006681:HLA-D Antigens